Stronger health and biotechnology
Effective health technologies and capable care services deliver sustained improvements in healthy life and access to treatment across population groups.
Why it matters
Better health improves wellbeing and working capacity while reducing avoidable care needs.
Signs it has been reached
- Healthy life expectancy improves across population groups
- Effective treatments reach more eligible patients
- Preventable illness and unmet care needs decline
Met when
The mean score of these 3 capability groups rises half a band (1.5 points).
- Health System Capability
- Population Health
- Biotechnology & Health Technologies
Held by all three panel models.
Reverse stress test
Working backwards from this outcome to the scenarios and conditions most likely to produce it, nation by nation, over 10 years.
- Nations with a route
- 85
- of 197 · 8 reach the Frontier band
- Typical likelihood
- none
- median nation, over 10 years
- Leads most routes
- Outbreak defence succeeds
- 48 of 85 nations
- Typical headroom
- ×3.5
- times Standard Severe, nearest single scenario
What produces it
Each nation’s most likely route, counted three ways: the scenario that does most of the work, the form the route takes, and the capability where a change would move the result most.
Lead scenario
Nations
Form of the route
Nations
Two scenarios together
One scenario at Standard Severe
One scenario at Extreme
75
6
4
Binding capability
Nations
Biotechnology & Health Technologies
Information Environment & Strategic Communication
Health System Capability
Fiscal Capacity & Public Finance
Regulatory Governance & Strategic Controls
57
12
4
4
4
Likelihood, by region
One dot per nation. The bar marks each region’s mean. Further right is more likely.
- North America
- Europe
- China
- Indo-Pacific
- South Asia
- Gulf and Middle East
- Africa
- Latin America and Caribbean
- Russia and Eurasia
Most likely: Germany 26%, France 26%, United Kingdom 26%, South Korea 26%, Canada 25%.
Who is in a position to take it?
Each nation’s score on this basket today against the likelihood of the outcome.
- North America
- Europe
- China
- Indo-Pacific
- South Asia
- Gulf and Middle East
- Africa
- Latin America and Caribbean
- Russia and Eurasia
All 197 nations
The route shown is the most likely one, and the basket column shows the band the nation would move to. A full band is the same fall for every nation: for a strong nation it is serious but leaves it well above where a weak nation starts. Where no route was found, the closest approach is the furthest any condition moved the basket, against the 1.5 points needed.
All 197 nations
197 of 197 nations
Rank | Nation | Region | Basket | Likelihood | 3 years | Most likely route | Headroom | Moves first | Lever |
|---|---|---|---|---|---|---|---|---|---|
| 2 | Germany | Europe | 16.8 Advanced → Frontier | 26% Highly likely | 8.2% | Chronic disease advance Severe | ×0.9 S20 | Health System Capability · reaches Frontier | Communications & Digital Infrastructure 16.4 |
| 1 | France | Europe | 16.7 Advanced → Frontier | 26% Highly likely | 8.2% | Chronic disease advance Severe | ×0.9 S20 | Health System Capability · reaches Frontier | Fiscal Capacity & Public Finance 16.5 |
| 3 | United Kingdom | Europe | 16.6 Advanced → Frontier | 26% Highly likely | 8.2% | Chronic disease advance Severe | ×0.9 S19 | Health System Capability · reaches Frontier | Health System Capability 16.3 |
| 4 | South Korea | Indo-Pacific | 16.3 Advanced → Advanced | 26% Highly likely | 8.1% | Automated discovery step Severe | ×0.9 S20 | Biotechnology & Health Technologies | Artificial Intelligence 16 |
| 5 | Canada | North America | 16.2 Advanced → Advanced | 25% Highly likely | 8.0% | Chronic disease advance Severe | ×0.8 S19 | Health System Capability | Biotechnology & Health Technologies 15.8 |
| 6 | Taiwan | Indo-Pacific | 14.8 Established → Advanced | 21% Likely | 6.7% | Chronic disease advance Major+Outbreak defence succeeds Major | ×1.0 S20 | Health System Capability | Biotechnology & Health Technologies 13.2 |
| 7 | Netherlands | Europe | 16.6 Advanced → Frontier | 21% Likely | 6.6% | Chronic disease advance Major+Outbreak defence succeeds Major | ×0.9 S20 | Health System Capability · reaches Frontier | Information Environment & Strategic Communication 13.7 |
| 8 | Japan | Indo-Pacific | 17.0 Advanced → Frontier | 21% Likely | 6.5% | Automated discovery step Major+Outbreak defence succeeds Major | ×0.9 S20 | Biotechnology & Health Technologies · reaches Frontier | Information Environment & Strategic Communication 15.7 |
| 9 | Sweden | Europe | 16.8 Advanced → Frontier | 20% Likely | 6.4% | Chronic disease advance Major+Outbreak defence succeeds Major | ×0.9 S20 | Health System Capability · reaches Frontier | Information Environment & Strategic Communication 14 |
| 10 | Switzerland | Europe | 17.0 Advanced → Frontier | 20% Likely | 6.4% | Chronic disease advance Major+Outbreak defence succeeds Major | ×1.0 S20 | Health System Capability · reaches Frontier | Information Environment & Strategic Communication 12.7 |
| 11 | Australia | Indo-Pacific | 16.3 Advanced → Advanced | 19% Likely | 5.8% | Chronic disease advance Severe | ×0.9 S19 | Health System Capability | Biotechnology & Health Technologies 15.2 |
| 12 | Singapore | Indo-Pacific | 16.1 Advanced → Advanced | 16% Likely | 5.0% | Automated discovery step Major+Outbreak defence succeeds Major | ×0.8 S20 | Biotechnology & Health Technologies | Information Environment & Strategic Communication 14.3 |
| 13 | Israel | Gulf and Middle East | 15.3 Advanced → Advanced | 16% Likely | 5.0% | Automated discovery step Major+Chronic disease advance Major | ×1.0 S19 | Biotechnology & Health Technologies | Fiscal Capacity & Public Finance 14.8 |
| 14 | Belgium | Europe | 15.6 Advanced → Advanced | 15% Likely | 4.8% | Chronic disease advance Major+Outbreak defence succeeds Major | ×1.0 S20 | Health System Capability | Information Environment & Strategic Communication 11 |
| 15 | Finland | Europe | 15.8 Advanced → Advanced | 15% Likely | 4.7% | Chronic disease advance Major+Outbreak defence succeeds Major | ×1.0 S20 | Health System Capability | Information Environment & Strategic Communication 12.7 |
| 17 | Denmark | Europe | 16.1 Advanced → Advanced | 13% Likely | 4.1% | Chronic disease advance Major+Outbreak defence succeeds Major | ×1.0 S20 | Health System Capability | Information Environment & Strategic Communication 12 |
| 18 | Spain | Europe | 15.0 Established → Advanced | 13% Likely | 4.1% | Chronic disease advance Major+Outbreak defence succeeds Major | ×1.1 S19 | Health System Capability | Biotechnology & Health Technologies 13.6 |
| 16 | Norway | Europe | 15.3 Advanced → Advanced | 13% Likely | 4.1% | Chronic disease advance Major+Outbreak defence succeeds Major | ×1.1 S20 | Health System Capability | Biotechnology & Health Technologies 12 |
| 19 | China | China | 14.4 Established → Advanced | 11% Likely | 3.3% | Automated discovery step Major+Outbreak defence succeeds Severe | ×1.1 S17 | Biotechnology & Health Technologies | Regulatory Governance & Strategic Controls 13.3 |
| 20 | Italy | Europe | 14.5 Established → Advanced | 10% Likely | 3.1% | Chronic disease advance Major+Outbreak defence succeeds Severe | ×1.2 S20 | Health System Capability | Information Environment & Strategic Communication 13 |
| 21 | Austria | Europe | 14.8 Established → Advanced | 10% Likely | 3.1% | Chronic disease advance Major+Outbreak defence succeeds Severe | ×1.2 S20 | Health System Capability | Information Environment & Strategic Communication 10.3 |
| 22 | Ireland | Europe | 13.4 Established → Advanced | 8.1% Likely | 2.4% | Chronic disease advance Major+Outbreak defence succeeds Severe | ×1.2 S20 | Health System Capability | Biotechnology & Health Technologies 11 |
| 24 | Czechia | Europe | 12.3 Established → Established | 7.6% Likely | 2.3% | Chronic disease advance Major+Outbreak defence succeeds Severe | ×1.3 S20 | Health System Capability | Biotechnology & Health Technologies 9.8 |
| 23 | Poland | Europe | 12.2 Established → Established | 7.6% Likely | 2.3% | Chronic disease advance Major+Outbreak defence succeeds Severe | ×1.3 S20 | Health System Capability | Biotechnology & Health Technologies 11.2 |
| 25 | Türkiye | Gulf and Middle East | 11.8 Transitional → Established | 7.4% Likely | 2.2% | Chronic disease advance Major+Outbreak defence succeeds Severe | ×1.2 S19 | Health System Capability | Biotechnology & Health Technologies 10.4 |
Showing 1–25 of 197 nations · page 1 of 8
Neighbouring outcomes
- Broad fall in critical technologyFailure outcome
- Broad rise in critical technologyProsperity outcome
- Broad fall in human capitalFailure outcome
- Broad rise in human capitalProsperity outcome
- Education pipeline failureFailure outcome
- Health system failureFailure outcome
- Adaptable skilled workforceProsperity outcome
A failure outcome is met when the basket falls a full band, which is three points. A prosperity outcome is met when the basket rises half a band, 1.5 points: in this model gains from a scenario are smaller and slower than losses, so the bar is set lower and the difference is stated.